Biblio
Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types. Front Oncol. 2023;13:1207081.
. .
GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. J Clin Lab Anal. 2022:e24662.
.